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Background: Hepatic pseudolesions detected by helical computed tomography (CT) are not rare, but it is difficult
to make a final diagnosis when the hepatic lesion is complicated by the presence of greatly elevated alpha
fetoprotein (AFP). Clinical treatment of non-typical hepatic pseudolesions complicated by greatly elevated AFP
should confirm the diagnosis and minimize trauma.
Case presentation: Non-invasive procedures including ultrasonography, CT, and micro-invasive digital subtraction
angiography could not safely differentiate this lesion from a malignant focus when it was complicated by greatly
elevated AFP. Laparoscopic hepatectomy was performed, and pathological analysis showed chronic hepatitis,
nodular regenerative hyperplasia, focal nodular hyperplasia of the liver, and mild vascular malformation. The tissue
was HbsAg(−), HbcAg(−), and AFP(+).
Conclusion: Heightened awareness of hepatic pseudolesion complicated by primarily elevated AFP will help
physicians avoid unnecessary invasive procedures. Hepatic biopsy is inevitable because of greatly elevated AFP. For
suspected hepatic pseudolesion with elevated AFP, needle-core biopsy and follow-up surveillance instead of
hepatectomy are recommended to find the source of AFP and make a final diagnosis of pseudolesion.
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Hepatic pseudolesions adjacent to the falciform ligament
have been observed using computed tomography (CT)
[1], but no specific disease has been related to these
pseudolesions [2,3]. When the hepatic lesion is compli-
cated by elevated alpha fetoprotein (AFP), the image
findings cannot be used to make a final clinical diagnosis
[4]. It is unclear which procedures should be performed
in this situation to confirm the diagnosis of hepatic
pseudolesion.
Here we present a case of a non-typical hepatic pseu-
dolesion observed on CT that was complicated by chronic
hepatitis and elevated AFP. We aimed to identify rational
clinical procedures that minimize trauma and that help* Correspondence: g_xlliu@126.com; g_hycui@126.com
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reproduction in any medium, provided the ordiagnose a non-typical hepatic pseudolesion complicated
by elevated AFP.
Case presentation
A 23-year-old woman presented with elevated AFP dur-
ing routine physical examination. There was no history
of viral hepatitis, drug abuse, or abdominal surgery. Her
AFP was 1,127 ng/ml, and she was negative for human
chorionic gonadotropin, hepatitis B virus, hepatitis C
virus, and hepatitis G virus. Her HbsAb was 748 IU/L.
Her other biochemical measures were as follows: aspar-
tate amino-transferase, 17 U/L; alanine aminotransfer-
ase, 13 U/L; albumin, 46 g/L; globulin, 31 g/L; and total
bilirubin, 12.7 μmol/L. Diseases of the reproductive and
urinary system that are associated with abnormal AFP
levels were excluded. A lesion in the liver was not detected
by ultrasonography, but we observed a blunt liver edge
and rough echo patterns throughout the liver, suggesting
chronic hepatic disease. Incremental helical CT was
performed to characterize the hepatic disease. A suspectedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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phases of helical CT with a 32-row detector in section IV
adjacent to the falciform ligament (Figure 1). A malignant
diagnosis could not be ruled out by the CT images.
We discussed the finding with the patient, who agreed
to be admitted and undergo digital subtraction angiog-
raphy (DSA) to rule out obvious vascular malformation or
a malignant lesion. The lesion was not obviously enhanced
in DSA, and no clear blood supply or arterial-portal fistula
was found (Figure 2). After further discussion with the pa-
tient (and as she knew magnetic resonance imaging (MRI)
might not safely tell the lesion with greatly elevated AFP
from a malignant one), she declined to await MRI and
demanded a biopsy of the liver and suspected lesion. To
avoid possible metastasis and a false-negative result by
needle biopsy, she agreed to laparoscopic hepatectomy
without Pringle’s hepatic inflow occlusion and intra-
operative ultrasonography (Figure 3). A wedge-shaped
hepatic specimen, 3 × 5 × 5 cm, was removed and sent
for pathological analysis (Figure 4A). Examination of
the frozen section showed no malignant cells. The for-
mal postoperative pathology results were as follows
(Figure 4B): 1) chronic hepatitis; 2) nodular regenerative
hyperplasia and focal nodular hyperplasia of the liver; 3)
mild vascular malformation; and 4) HbsAg(−), HbcAg
(−). Immunohistochemistry was performed, but no dif-
ference of AFP expression was found between hepatic
lesion (Figure 4C) and normal tissue (Figure 4D). No
surgical complications were seen. On postoperative day
7, the patient had Child A liver function and an AFP of
8,377 ng/ml. It was accepted that the elevated AFP
resulted from primary chronic hepatitis instead of aFigure 1 Computed tomography (CT) findings. In each panel, the arrow
(B) Arterial-dominant phase CT image. (C) Portal-dominant phase CT imagemalignant hepatic lesion. The patient was transferred to
the Department of Internal Medicine with a final diag-
nosis of hepatic pseudolesion and primary non-viral (B,
C, or G) chronic hepatitis. She received protocol includ-
ing dexamethasone and Compound Glycyrrhizin in the
Department of Internal Medicine. After another 2 weeks
of steroid and liver protection therapy, the patient was
discharged with an AFP of 46 ng/ml and Child A liver
function. One month after hepatectomy,no hepatic le-
sion was found by CT in the postoperative follow-up
(Figure 5).Discussion
Hepatic pseudolesion detected by CT that is complicated
primarily by elevated AFP is confusing since it is difficult
to rule out a malignant lesion using routine non-invasive
procedures. However, excessively invasive procedures are
associated with increased health risks. Ideally, clinical
procedures should confirm the diagnosis while minimiz-
ing invasion and cost.
Abnormal AFP with normal liver function and negative
viral evidence were the major factors that were confusing
in this case. AFP is produced by normal gastrointestinal
cells, yolk sac cells, and fetal hepatocytes after birth [5].
AFP levels above 20 ng/mL are considered indicative of
possible liver disease [6]. Among liver cirrhosis cases with-
out hepatocelluar carcinoma (HCC), AFP is reported to be
elevated in 20% and to exceed 100 ng/mL in only 3% [7].
An elevated AFP level has high diagnostic significance for
HCC, since the probability of HCC is >90% at an AFP
level of >200 ng/mL. However, the AFP level can also beindicates the pseudolesion. (A) Unenhanced phase CT image.
. (D) Equilibrium phase CT image.
Figure 2 Digital subtraction angiography using contrast
enhancement. The findings were not typical of a pseudolesion
from vascular malformation.
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tions [8].
Diseases outside the liver that are associated with
elevated AFP
Elevated AFP is a typical sign of pregnancy and teratoma
[9,10]. When hepatitis B virus, hepatitis C virus, and hepa-
titis G virus are negative and liver function is normal,
diseases outside the liver associated with elevated AFP, es-
pecially malignancies leading to hepatic metastasis, should
be excluded first [11]. Some laboratory tests, such as
human chorionic gonadotropin, ultrasonography, and
radiography, may help exclude misdiagnoses.
Non-invasive and micro-invasive procedures for
suspected hepatic pseudolesion
Ultrasonography is the first test that should be performed when
a hepatic lesion is suspected. Some hepatic pseudolesions,Figure 3 Intraoperative findings. Intraoperative ultrasonography.
The arrow indicates the location of the pseudolesion.such as the one caused by rib compression during CT, may
be negative in non-invasive transabdominal ultrasound
[12]. In the case presented here, the hepatic pseudolesion
was missed by non-invasive ultrasound but finally found by
intraoperative ultrasonography. Intraoperative ultrasonog-
raphy is more sensitive than non-invasive ultrasound, but it
is limited because it is more invasive [13]. A negative result
from non-invasive ultrasonography did not result in a
final diagnosis but did suggest the possibility of hepatic
pseudolesion.
CT and CT arterial portography images show hepatic
pseudolesions as areas of low attenuation with a triangu-
lar shape located adjacent to the falciform ligament;
these findings may indicate a pseudolesion with focal
fatty infiltration [14]. However, only 24.2% of pseudolesion
images persist in all phases of CT, and it may be difficult
to differentiate pseudolesions from other lesions [1]. In
the case we present, the hepatic lesion resulted from hep-
atic focal nodular hyperplasia and mild vascular malfor-
mation, and its appearance on CT was as an area of low
attenuation that was adjacent to the falciform ligament.
This led us to suspect primary pseudolesion.
MRI can be used to detect a pseudolesion [15], and
high-quality 3 T MRI has been reported to be helpful
in diagnosing a hypervascularpseudolesion [16]. Out-
of-phase T1 weighted MRI images show a loss of sig-
nal in the pseudolesion that is related to the presence
of microscopic fat [17]. However, fat deposition and
vascular malformation in MRI could not be safely dis-
tinguished from a malignant lesion [18]. Chronic hepa-
titis and abnormal AFP further complicated the case.
Thus, in this case the patient rejected to await MRI.
However, the final pathological result in this case
showed nodular regenerative hyperplasia and focal
nodular hyperplasia of the liver that might be found by
MRI [19]. Thus, regardless of hepatitis and abnormal
AFP, MRI is recommended to search for evidence of
hepatic pseudolesion.
DSA is a micro-invasive procedure that is usually
utilized to diagnose and treat HCC. Although a false
negative for HCC by DSA is a possibility, DSA can
differentiate a hepatic pseudolesion caused by vascular
malformation from a malignant lesion [20]. Unfortu-
nately, in the case presented here there was focal nodu-
lar hyperplasia and only mild vascular malformation;
thus, none of the typical signs of vascular malformation
were found by DSA.
Although AFP levels might be elevated in patients with
chronic liver disease, it seemed difficult to differentiate a
benign tumor with abnormal AFP from a malignant hep-
atic lesion using only laboratory tests and non-invasive
or micro-invasive procedures. Here, hepatic biopsy had
to be performed since pathological results were needed
to make a precise diagnosis.
Figure 4 Pathological findings. (A) An image of the gross hepatic specimen. The arrow indicates the pseudolesion. (B) The pathology sample
showed chronic hepatitis and liver regeneration (hematoxylin and eosin staining; magnification × 200). (C) Alpha fetoprotein (AFP) in nodular
regenerative hyperplasia tissue (immunohistochemical staining; magnification × 200). (D) AFP in normal tissue (immunohistochemical staining;
magnification × 200).
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In the case reported here, the lesion observed on the
CT images was interpreted as a suspected malignant
lesion after we performed laboratory tests, non-invasive
transabdominal ultrasound, and DSA. Laparoscopic
hepatectomy without the Pringle maneuver and hepatic
inflow occlusion was performed to avoid a false negative
and possible implantation metastasis due to needle-core
biopsy [21]. The lesion was small, adjacent to the infer-
ior surface of the liver, and located by intraoperative
ultrasonography. Because of these factors, hepatectomy
did not carry risks of severe surgical complications such
as hemorrhage, biliary fistula, and liver dysfunction.
However, the final pathological results revealed that the
elevated AFP was caused by primary non-viral (B, C,
or G) chronic hepatitis instead of the hepatic lesion.Figure 5 Postoperative computed tomography (CT) findings. In each p
image. (B) Arterial-dominant phase CT image. (C) Portal-dominant phase CDownregulation of AFP resulted from steroid and liver
protection therapy for hepatitis instead of surgery.
Needle-core biopsy followed by dynamic follow-up
surveillance may be less invasive than hepatectomy and
more appropriate for this kind of hepatic lesion.
Needle-core biopsy, including percutaneous liver biopsy
and transjugular liver biopsy, is mostly used to obtain a
pre-operative specimen that is useful for both HCC
diagnosis and grading [22]. Percutaneous liver biopsy is
appropriate to use for hepatic lesions that can be lo-
cated by non-invasive ultrasonography, CT, or MRI
[23]. For hepatic pseudolesion complicated by primary
non-viral (B, C, or G) hepatitis and abnormal AFP, re-
gardless of whether the hepatic lesion can be biopsied,
liver biopsy without contraindications is recommended
to further characterize the hepatic disease.anel, the arrow indicates the operative site. (A) Unenhanced phase CT
T image.
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Here we present a case of hepatic pseudolesion observed
by CT that was complicated by primary non-viral
chronic hepatitis (B, C, or G) with elevated AFP. This
pseudolesion may have been caused by focal nodular
hyperplasia of the liver plus mild vascular malformation.
This condition can present as areas with low attenuation
at all stages of enhanced CT. It is typically adjacent to
the falciform ligament and negative on non-invasive
ultrasonography and DSA.
Heightened awareness of hepatic pseudolesion compli-
cated by primary elevated AFP will help physicians avoid
unnecessary invasive procedures. Diseases outside the liver
that present with elevated AFP should be excluded first.
MRI is recommended to provide clues of pseudolesion.
Hepatic biopsy and follow-up surveillance rather than
hepatectomy are recommended when non-invasive and
micro-invasive procedures cannot provide enough evi-
dence for a final diagnosis. More knowledge on primary
non-viral (B, C, or G) chronic hepatitis with greatly ele-
vated AFP levels and Child A liver function is in need.
Additional procedures that are less invasive are needed to
better diagnose and treat hepatic pseudolesion compli-
cated by primary hepatitis with abnormal AFP.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Series Editor of this journal.
Ethical considerations
The patient provided permission to publish this report,
and the report was approved by the Ethics Board of the
Third Affiliated Hospital of Southern Medical Univer-
sity, China.
Abbreviations
AFP: Alpha fetoprotein; CT: Computed tomography; DSA: Digital subtraction
angiography; HCC: Hepatocellular carcinoma; MRI: Magnetic resonance
imaging.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
XLL collected clinical data and composed the manuscipt. FQL reviewed the
paper. Clinical treatment was performed under instruction from LXL and
HYC. LYZ and YHL analyzed the images. QZW was responsible for the result
of pathological consultation. All authors read and approved the final
manuscript.
Acknowledgments
We appreciate the expertise of Dr Juan Luo, who performed the ultrasound
scan. We are grateful to the patient who allowed us to share our findings.
Author details
1Department of General Surgery, Third Affiliated Hospital of Southern
Medical University, Guangzhou 510630, PR China. 2Department of Radiology,
Third Affiliated Hospital of Southern Medical University, Guangzhou 510630,PR China. 3Department of General Surgery, First Affiliated Hospital, Zhejiang
University School of Medicine, Hangzhou 310003, PR China. 4Department of
Pathology, Third Affiliated Hospital of Southern Medical University,
Guangzhou 510630, PR China. 5Department of Internal Medicine, Third
Affiliated Hospital of Southern Medical University, Guangzhou 510630, PR
China.
Received: 26 February 2013 Accepted: 11 September 2013
Published: 23 September 2013
References
1. Koseoglu K, Ozsunar Y, Taskin F, Karaman C: Pseudolesions of left liver
lobe during helical CT examinations: prevalence and comparison
between unenhanced and biphasic CT findings. Eur J Radiol 2005,
54:388–392.
2. Kakihara D, Yoshimitsu K, Naito S, Masuda K: A large pseudolesion in the
left lobe of the liver caused by inferior vena caval obstruction secondary
to metastatic retroperitoneal lymphadenopathy. Comput Med Imaging
Graph 2000, 24:253–257.
3. Nakayama T, Yoshimitsu K, Masuda K: Pseudolesion in segment IV of the
liver with focal fatty deposition caused by the parabiliary venous
drainage. Comput Med Imaging Graph 2000, 24:259–263.
4. Hori M, Murakami T, Kim T, Nakamura H: Diagnosis of hepatic neoplasms
using CT arterial portography and CT hepatic arteriography. Tech Vasc
Interv Radiol 2002, 5:164–169.
5. Zhou YM, Yang JM, Li B, Sasaki M, Hokotate H, Baba Y: Risk factors for early
recurrence of small hepatocellular carcinoma after curative resection.
Hepatobiliary Pancreas Dis Int 2010, 9:33–37.
6. Eleftheriou N, Heathcote J, Thomas HC, Sherlock S: Serum alpha-
fetoprotein levels in patients with acute and chronic liver disease.
Relation to hepatocellular regeneration and development of primary
liver cell carcinoma. J ClinPathol 1977, 30:704–708.
7. Snowberger N, Chinnakotla S, Lepe RM, Peattie J, Goldstein R, Klintmalm GB,
Davis GL: Alpha fetoprotein, ultrasound, computerized tomography and
magnetic resonance imaging for detection of hepatocellular carcinoma
in patients with advanced cirrhosis. Aliment Pharmacol Ther 2007,
26:1187–1194.
8. Di Carlo I, Mannino M, Toro A, Ardiri A, Galia A, Cappello G, Bertino G:
Persistent increase in alpha-fetoprotein level in a patient without
underlying liver disease who underwent curative resection of
hepatocellular carcinoma. A case report and review of the literature.
World J Surg Oncol 2012, 10:79.
9. Tjalma WA: The value of AFP in congenital cervical teratoma. J Pediatr
Surg 2003, 38:1846.
10. Bredaki FE, Wright D, Akolekar R, Cruz G, Nicolaides KH: Maternal serum
alpha-fetoprotein in normal pregnancy at 11–13 weeks' gestation.
Fetal Diagn Ther 2011, 30:274–279.
11. Hartmann JT, Rick O, Oechsle K, Kuczyk M, Gauler T, Schöffski P, Schleicher J,
Mayer F, Teichmann R, Kanz L, Bokemeyer C: Role of postchemotherapy
surgery in the management of patients with liver metastases from germ
cell tumors. Ann Surg 2005, 242:260–266.
12. Nishie A, Yoshimitsu K, Irie H, Aibe H, Tajima T, Asayama Y, Matake K,
Ishigami K, Nakayama T, Kakihara D, Honda H: The incidence of hepatic
pseudolesions caused by focal rib compression as seen on multidetector
row CT in patients of different hepatic function. Eur J Radiol 2006,
57:108–114.
13. Spitz JD, Lilly MC, Tetik C, Arregui ME: Ultrasound-guided laparoscopic
resection of pancreatic islet cell tumors. Surg Laparosc Endosc Percutan
Tech 2000, 10:168–173.
14. Fukukura Y, Fujiyoshi F, Inoue H, Sasaki M, Hokotate H, Baba Y, Nakajo M:
Focal fatty infiltration in the posterior aspect of hepatic segment IV:
relationship to pancreaticoduodenal venous drainage. Am J Gastroenterol
2000, 95:3590–3595.
15. Ito K, Honjo K, Fujita T, Awaya H, Matsumoto T, Matsunaga N: Hepatic
parenchymal hyperperfusion abnormalities detected with multisection
dynamic MR imaging: appearance and interpretation. J Magn Reson
Imaging 1996, 6:861–867.
16. Fruehwald-Pallamar J, Bastati-Huber N, Fakhrai N, Jantsch M, Puchner S,
Herneth AM, Ba-Ssalamah A: Confident non-invasive diagnosis of
pseudolesions of the liver using diffusion-weighted imaging at 3T MRI.
Eur J Radiol 2012, 81:1353–1359.
Liu et al. World Journal of Surgical Oncology 2013, 11:238 Page 6 of 6
http://www.wjso.com/content/11/1/23817. Macari M, Yeretsian R, Babb J: Assessment of low signal adjacent to the
falciform ligament on contrast-enhanced MRI. Am J Roentgenol 2007,
189:1443–1448.
18. Kanematsu M, Kondo H, Semelka RC, Matsuo M, Goshima S, Hoshi H,
Moriyama N, Itai Y: Early-enhancing non-neoplastic lesions on
gadolinium-enhanced MRI of the liver. Clin Radiol 2003, 58:778–786.
19. Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B,
Gambarini S, Donato F, Colagrande S: Hepatocellular adenoma and focal
nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in
differential diagnosis. Radiology 2012, 262:520–529.
20. Iwazawa J, Ohue S, Mitani T, Abe H, Hashimoto N, Hamuro M, Nakamura K:
Identifying feeding arteries during TACE of hepatic tumors: comparison
of C-arm CT and digital subtraction angiography. Am J Roentgenol 2009,
192:1057–1063.
21. Binitie O, Tejiram S, Conway S, Cheong D, Temple HT, Letson GD: Adult soft
tissue sarcoma local recurrence after adjuvant treatment without resection
of core needle biopsy tract. Clin Orthop Relat Res 2013, 471:891–898.
22. Kalambokis G, Manousou P, Vibhakorn S, Marelli L, Cholongitas E, Senzolo
M, Patch D, Burroughs AK: Transjugular liver biopsy–indications,
adequacy, quality of specimens, and complications–a systematic review.
J Hepatol 2007, 47:284–294.
23. Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, Ghany MG, Shiffman
ML, Fontana RJ, Di Bisceglie AM, Bonkovsky HL, Dienstag JL, HALT-C Trial
Group: Complication rate of percutaneous liver biopsies among persons
with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol
Hepatol 2010, 8:877–883.
doi:10.1186/1477-7819-11-238
Cite this article as: Liu et al.: Treatment of a non-typical hepatic
pseudolesion complicated by greatly elevated alpha fetoprotein: case
report and literature review. World Journal of Surgical Oncology
2013 11:238.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
